Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients

Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status... J Cancer Res Clin Oncol (2017) 143:1745–1756 DOI 10.1007/s00432-017-2431-5 ORIGINAL ARTICLE – CANCER RESEARCH Impact of intra‑tumoral IL17A and IL32 gene expression on T‑cell responses and lymph node status in breast cancer patients 1 1,5 1 1 Shreyas Bhat · Nilesh Gardi · Sujata Hake · Nirupama Kotian · 1 2 3,5 4,5 Sharada Sawant · Sadhana Kannan · Vani Parmar · Sangeeta Desai · 1,5 1,5 Amit Dutt · Narendra N. Joshi Received: 5 February 2016 / Accepted: 20 April 2017 / Published online: 3 May 2017 © Springer-Verlag Berlin Heidelberg 2017 Abstract in the latter group (26.2 vs 7.1-fold, p < 0.01). ER-negative Purpose Pro-inflammatory cytokines such as Interleukin- tumors also showed higher expression of IL32 as opposed 17A (IL17A) and Interleukin-32 (IL32), known to enhance to ER-positive tumors (8.7 vs 2.5-fold, p < 0.01). Expres- natural killer and T cell responses, are also elevated in sion of both IL17A and IL32 genes positively correlated human malignancies and linked to poor clinical outcomes. with CCL5, GNLY, TBX21, IL21 and IL23 transcript lev- To address this paradox, we evaluated relation between els (p < 0.01). Amongst ER-positive tumors, higher IL32 IL17A and IL32 expression and other inflammation- and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cancer Research and Clinical Oncology Springer Journals

Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients

Loading next page...
 
/lp/springer_journal/impact-of-intra-tumoral-il17a-and-il32-gene-expression-on-t-cell-6KthrhT3t8
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Oncology; Cancer Research; Internal Medicine; Hematology
ISSN
0171-5216
eISSN
1432-1335
D.O.I.
10.1007/s00432-017-2431-5
Publisher site
See Article on Publisher Site

Abstract

J Cancer Res Clin Oncol (2017) 143:1745–1756 DOI 10.1007/s00432-017-2431-5 ORIGINAL ARTICLE – CANCER RESEARCH Impact of intra‑tumoral IL17A and IL32 gene expression on T‑cell responses and lymph node status in breast cancer patients 1 1,5 1 1 Shreyas Bhat · Nilesh Gardi · Sujata Hake · Nirupama Kotian · 1 2 3,5 4,5 Sharada Sawant · Sadhana Kannan · Vani Parmar · Sangeeta Desai · 1,5 1,5 Amit Dutt · Narendra N. Joshi Received: 5 February 2016 / Accepted: 20 April 2017 / Published online: 3 May 2017 © Springer-Verlag Berlin Heidelberg 2017 Abstract in the latter group (26.2 vs 7.1-fold, p < 0.01). ER-negative Purpose Pro-inflammatory cytokines such as Interleukin- tumors also showed higher expression of IL32 as opposed 17A (IL17A) and Interleukin-32 (IL32), known to enhance to ER-positive tumors (8.7 vs 2.5-fold, p < 0.01). Expres- natural killer and T cell responses, are also elevated in sion of both IL17A and IL32 genes positively correlated human malignancies and linked to poor clinical outcomes. with CCL5, GNLY, TBX21, IL21 and IL23 transcript lev- To address this paradox, we evaluated relation between els (p < 0.01). Amongst ER-positive tumors, higher IL32 IL17A and IL32 expression and other inflammation- and

Journal

Journal of Cancer Research and Clinical OncologySpringer Journals

Published: May 3, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off